Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 16 (Suppl 2), S347-9

Dyslipidemia in Subclinical Hypothyroidism and the Effect of Thyroxine on Lipid Profile


Dyslipidemia in Subclinical Hypothyroidism and the Effect of Thyroxine on Lipid Profile

Ajay Asranna et al. Indian J Endocrinol Metab.


Introduction: Subclinical hypothyroidism (SH) has a prevalence between 4% and 10.5% in various studies. The burden of SH in India is expected to increase with increasing iodine sufficiency. Studies have shown conflicting results concerning not only the degree of lipid changes in SH but also the effect of thyroxine substitution therapy. Indian studies on dyslipidemia in SH and the effect of thyroxine on lipid profile are currently lacking.

Aims and objectives: (1) To assess the association of SH and lipid profile. (2) To quantify the effect of thyroxine treatment on lipid profile.

Materials and methods: About 54 patients who were detected to have SH were compared with 56 healthy controls. Thyroid stimulating hormone (TSH), free T3, free T4, anti thyroperoxidase (TPO) antibodies, total cholesterol, high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, Very low density lipoprotein (VLDL) cholesterol, serum triglycerides were measured in all the patients after an overnight fast. Selected patients were started on thyroxine replacement. Twenty-one patients were followed up after 3 months with a repeat lipid profile.

Results: Mean total cholesterol and mean LDL levels were significantly higher in SH compared to controls, but there was no statistically significant difference in the mean HDL, VLDL, and triglyceride levels. There was a significant reduction in mean T. cholesterol, mean LDL, mean VLDL, and mean triglyceride levels after treatment with thyroxine, while there was no significant difference among the mean HDL levels.

Conclusion: Dyslipidemia is more common in SH compared to controls. There is a TSH dependent increase in cholesterol, LDL, VLDL, and triglyceride levels. Achieving euthyroid status with thyroxine has a favourable effect on lipid profile.

Keywords: Dyslipidemia; subclinical hypothyoridsm; thyroxine.

Conflict of interest statement

Conflict of Interest: None declared

Similar articles

See all similar articles

Cited by 5 articles


    1. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526–34. - PubMed
    1. Singh Kuldip, Singh Saranpal. Alteration in lipid fractions in subclinical Hypothyroidism in North Indian population. Indian J Fundam Appl Life Sci. 2011;1:127–32.
    1. Bandyopadhyay SK, Basu AK, Pal SK, Roy P, Chakrabarti S, Pathak HS, et al. A study on dyslipidaemia in subclinical hypothyroidism. J Indian Med Assoc. 2006;104:622–4. 626. - PubMed
    1. Tanis BC, Westendorp GJ, Smelt HM. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: A reanalysis of intervention studies. Clin Endocrinol (Oxf) 1996;44:643–9. - PubMed
    1. Danese MD, Ladenson PW, Meinert CL, Powe NR. Clinical review 115: Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: A quantitative review of the literature. J Clin Endocrinol Metab. 2000;85:2993–3001. - PubMed

LinkOut - more resources